Pharma News

The World Health Organization (WHO) has revealed that lindane, an insecticide, widely used in agriculture and to treat human lice and scabies, can cause cancer and associated to occurrence of non-Hodgkin lymphoma, a rare kind of cancer. International Agency for Research in Cancer (IARC's)  specialist panel classified lindane as "carcinogenic to humans" in its Group 1 category, DDT as "probably carcinogenic to humans" in its Group 2A class, and the herbicide 2,4-D as "possibly carcinogenic to humans" in its Group 2B.

Scientist  have found that a drug used to treat skin cancer may slow the onset of age-related deaths by slowing the aging process in fruit flies. The study was printed in the journal Cell.

Ricoh India, a wholly-owned subsidiary of Japanese imaging and electronics major Ricoh, launched  a new medical imaging solution called ‘Picasso’ (Patient is Central to this Advanced Solution and Service Offering) recently in Hyderabad. Picaso is web-based multi-specialty cloud-enabled imaging solution. The new innovative medical imaging solution is designed to offer benefits to patients, radiologists, consultants and hospitals and drastic reduction in the healthcare costs for the patients.

Head and neck cancers affect nearly 50,000 people in the United States each year. The main risk factors include alcohol, smoking and human papillomavirus (HPV), a common sexually transmitted infection that often goes undetected. Researchers at Johns Hopkins University have developed a new test that uses blood and saliva to detect head and neck cancers.  The research is published in Science Translational Medicine.

(NewsVoir); 1mg.com, India’s leading m-health platform, today launched ‘Doctors by 1mg’ on the Android platform, to help Delhi NCR discover best doctors and book appointments. A companion to the 1mg App which is the leading consumer health platform with over 3 M downloads, the new launch demonstrates company’s commitment towards building a platform that will aid users in managing their health effectively.

Jubilant Life Sciences has announced that it had received approval of the US Food and Drug Administration (FDA) for its tablets used in treating adults for various infections, including pneumonia. The market size for Levofloxacin is estimated to be $28 million (Rs.179 crore) per annum.

TAKE Solutions Ltd., a global business technology solutions provider, was awarded a patent by the United States Patent and Trademark Office (USPTO) for its "Method for Optimizing Clinical Data Standardization". It provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods. TAKE’s global headquarters is in Chennai, India; its US headquarters is located in Princeton, New Jersey. This process leverages TAKE Solutions’ clinical accelerators to reduce the time taken to standardize trial data by over 50% (when compared to standardization without the accelerators), thus reducing time to market.

[adsense:336x280:8701650588]

Maruishi Pharmaceutical Co., Ltd.  & Daiichi Sankyo Company, Limited, a global pharmaceutical company Collaborate to commercialize the general anaesthesia analgesic, remifentanil injection generic. Maruishi Pharmaceutical is currently applying for a manufacture and marketing license. Once Maruishi Pharmaceutical has acquired a license for the manufacturing and marketing of this drug, the plan is for Maruishi Pharmaceutical to handle its manufacture and Daiichi Sankyo to handle its marketing, while both companies will jointly conduct promotion activities.

Researchers have developed a new test that can detect every known human virus that currently or previously infected a person from a single drop of blood. The method developed by Howard Hughes Medical Institute (HHMI) researchers can test for current and past infections with any known human virus, including HIV and hepatitis C.